[在胃肠病中使用与相竞争的阻断剂的现状和前景]
I V Maev1, D N Andreev1, A V Zaborovsky1
1Russian University of Medicine.
Terapevticheskii arkhiv
|August 30, 2025
概括
与相竞争的酸阻断剂 (P-CAB) 提供了一种减少胃酸的新方法,克服了传统的质子抑制剂 (PPI) 的局限性. 对于像GERD和H. pylori感染这样的疾病,P-CAB可以提供更快,更持久的酸性控制.
科学领域:
- 胃肠病学
- 药理学
- 分子生物学
背景情况:
- 质子抑制剂 (PPI) 长期以来一直是控制胃酸的标准.
- 然而,PPI具有局限性,包括由于CYP2C19基因的缓慢发作,可变的疗效和依赖酸的激活.
- 这些缺点凸显了需要替代性抑制酸的策略.
研究的目的:
- 引入竞争性酸阻断剂 (P-CABs) 作为一种用于胃酸控制的新疗法.
- 与PPI相比,阐明P-CAB的不同作用机制.
- 审查P-CAB在治疗酸性疾病中的临床相关性和益处.
主要方法:
- 对P-CAB和PPI进行比较的现有文献和元分析的审查.
- 与H+/K+-ATPase发生可逆离子相互作用的P-CAB的分子机制的解释.
- 对胃食道反流病,胃和H. pylori根除中的P- CAB疗效的临床数据分析.
主要成果:
- P-CAB 是一种抑制胃酸分泌的新机制.
- 它们通过直接向H+/K+-ATPase提供快速和持续的酸性抑制.
- 在关键的胃肠道症状中,P-CAB比PPI具有更高的临床益处.
结论:
- 在胃酸管理方面,P-CAB提供了比PPI更有效和更快的替代品.
- 它们的直接酶抑制机制改善了基底和刺激酸分泌的控制.
- 在治疗酸性疾病和H. pylori根除方面,P-CAB显著有前途.
更多相关视频
相关概念视频
Acid Suppressive Drugs for Peptic Ulcer Disease: Proton Pump Inhibitors
525
Peptic ulcers, often induced by H. pylori infections or NSAID usage, arise from disruptions in the delicate balance of gastric acid production. Peptic ulcers stem from heightened gastric acid levels due to H. pylori infections or NSAID use. The protective mucus layer diminishes in the presence of these factors, allowing gastric acid to erode the stomach lining and form ulcers.
Gastric acid, a potent cocktail of hydrogen and chloride ions, is produced in specialized parietal cells within the...
Gastric acid, a potent cocktail of hydrogen and chloride ions, is produced in specialized parietal cells within the...
525
Acid Suppressive Drugs for Peptic Ulcer Disease: Histamine H2-Receptor Antagonists
569
Histamine H2 receptors, which are intricately located on the basolateral membrane of parietal cells, play a crucial role in modulating gastric acid secretion. When released from enterochromaffin-like cells, histamine engages H2 receptors, initiating the cyclic AMP (cAMP) pathway. In this pathway, adenylyl cyclase converts ATP into cAMP, elevating intracellular cAMP levels. The activation of protein kinase A follows, stimulating the proton pump. This stimulation prompts the secretion of hydrogen...
569
Antihypertensive Drugs: Potassium-Sparing Diuretics
751
Liddle syndrome is a genetically inherited form of hypertension characterized by the overactivity of epithelial sodium channels in the nephron, the functional unit of the kidney. This heightened activity leads to increased sodium reabsorption and excessive excretion of potassium. To counteract this, potassium-sparing diuretics such as amiloride are used. They function by blocking these sodium channels, thereby reducing the influx of sodium into the epithelial cells and minimizing the loss of...
751
Acid Suppressive Drugs for Peptic Ulcer Disease: Antacids
444
In the complex environment of the gastric lumen, excessive acid secretion can lead to the formation or worsening of ulcers within the delicate mucosal layer. Antacids, such as sodium bicarbonate and calcium carbonate, provide relief by neutralizing this acid, transforming it into harmless salt and water. This neutralization process raises the gastric pH from a highly acidic level of 1 to a more basic 3-4, reducing the acidity within the stomach.
However, this neutralization reaction between...
However, this neutralization reaction between...
444
Nondepolarizing (Competitive) Neuromuscular Blockers: Pharmacokinetics
526
All neuromuscular blocking agents are injected intravenously because they are poorly absorbed from the GI tract. Rapid onset is achieved with intravenous administration, although absorption is also adequate from an intramuscular injection. Since these agents are highly ionized, they do not readily penetrate cell membranes or cross the blood-brain barrier.
Instead, they are transported by the blood to different tissues. Muscles with a greater blood supply (arteries) and blood flow receive more...
Instead, they are transported by the blood to different tissues. Muscles with a greater blood supply (arteries) and blood flow receive more...
526
Nondepolarizing (Competitive) Neuromuscular Blockers: Pharmacological Actions
525
Nondepolarizing neuromuscular blockers prevent the membrane depolarization of muscle cells and inhibit muscle contraction. These are usually administered with anesthetics to achieve complete muscle relaxation. Upon administration, these drugs first block the small, rapidly contracting muscles of the face and hands, followed by the larger muscles of the trunk and the intercostal muscles. The diaphragm is the last muscle to be affected.
Although all competitive neuromuscular blockers are designed...
Although all competitive neuromuscular blockers are designed...
525


